losartan has been researched along with Carcinoma, Renal Cell in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, WF | 1 |
| Naves, MA | 1 |
| Ravanini, JN | 1 |
| Schor, N | 1 |
| Teixeira, VP | 1 |
| Jankovic, SM | 1 |
| Stojadinovic, D | 1 |
| Stojadinovic, M | 1 |
| Jankovic, SV | 1 |
| Djuric, JM | 1 |
| Stojic, I | 1 |
| Kostic, M | 1 |
| Zhuo, J | 1 |
| Dean, R | 1 |
| MacGregor, D | 1 |
| Alcorn, D | 1 |
| Mendelsohn, FA | 1 |
3 other studies available for losartan and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carc | 2015 |
Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2016 |
Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Autoradiography; Binding, Competitive; Biph | 1996 |